Carlton Hofferkamp & Jenks Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $216K | Sell |
|
|||||
|
2022
Q3 | $221K | Sell |
|
|||||
|
2022
Q2 | $382K | Sell |
|
|||||
|
2022
Q1 | $428K | Sell |
|
|||||
|
2021
Q4 | $427K | Sell |
|
|||||
|
2021
Q3 | $445K | Sell |
|
|||||
|
2021
Q2 | $419K | Sell |
|
|||||
|
2021
Q1 | $427K | Sell |
|
|||||
|
2020
Q4 | $492K | Sell |
|
|||||
|
2020
Q3 | $537K | Buy |
|
|||||
|
2020
Q2 | $470K | Sell |
|
|||||
|
2020
Q1 | $487K | Buy |
|
|||||
|
2019
Q4 | $519K | Sell |
|
|||||
|
2019
Q3 | $476K | Sell |
|
|||||
|
2019
Q2 | $472K | Buy |
|
|||||
|
2019
Q1 | $479K | Sell |
|
|||||
|
2018
Q4 | $589K | Sell |
|
|||||
|
2018
Q3 | $746K | Sell |
|
|||||
|
2018
Q2 | $748K | Sell |
|
|||||
|
2018
Q1 | $765K | Sell |
|
|||||
|
2017
Q4 | $747K | Sell |
|
|||||
|
2017
Q3 | $1.12M | Buy |
|
|||||
|
2017
Q2 | $1.16M | Buy |
|
|||||
|
2017
Q1 | $1.13M | Sell |
|
|||||
|
2016
Q4 | $1.04M | Sell |
|
|||||
|
2016
Q3 | $1.28M | Sell |
|
|||||
|
2016
Q2 | $1.34M | Sell |
|
|||||
|
2016
Q1 | $1.26M | Buy |
|
|||||
|
2015
Q4 | $1.25M | Sell |
|
|||||
|
2015
Q3 | $1.29M | Sell |
|
|||||
|
2015
Q2 | $1.42M | Buy |
|
|||||
|
2015
Q1 | $1.5M | Buy |
|
|||||
|
2014
Q4 | $1.38M | Sell |
|
|||||
|
2014
Q3 | $1.8M | Buy |
|
|||||
|
2014
Q2 | $801K | Buy |
|